User profiles for Janet T Scott
 | Janet T ScottMRC-University of Glasgow Centre for Virus Research Verified email at glasgow.ac.uk Cited by 5198 |
[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
…, CJ Sands, JT Scott, L Sigfrid, T Solomon… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …
was announced, containing far more mutations in Spike (S) than previously reported …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
[HTML][HTML] Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation …
Background This study sought to establish the long-term effects of Covid-19 following
hospitalisation. Methods 327 hospitalised participants, with SARS-CoV-2 infection were recruited …
hospitalisation. Methods 327 hospitalised participants, with SARS-CoV-2 infection were recruited …
[HTML][HTML] Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study
Background The long-term sequelae of coronavirus disease 2019 (COVID-19) in children
remain poorly characterised. This study aimed to assess long-term outcomes in children …
remain poorly characterised. This study aimed to assess long-term outcomes in children …
[HTML][HTML] Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study
With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential
to inform health and social care support. A Scottish population cohort of 33,281 laboratory-…
to inform health and social care support. A Scottish population cohort of 33,281 laboratory-…
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study
…, A Guekht, JO Warner, L Sigfrid, JT Scott… - The Lancet …, 2022 - thelancet.com
Health consequences that persist beyond the acute infection phase of COVID-19, termed
post-COVID-19 condition (also commonly known as long COVID), vary widely and represent a …
post-COVID-19 condition (also commonly known as long COVID), vary widely and represent a …
[HTML][HTML] Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
…, V Sancho-Shimizu, JT Scott, T de Silva… - The Lancet …, 2021 - thelancet.com
Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …
cases are urgently required to inform clinical management decisions. Methods We …
[HTML][HTML] Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective …
…, DL Robertson, V Sancho-Shimizu, JT Scott, T de Silva… - The Lancet, 2021 - thelancet.com
Background COVID-19 is a multisystem disease and patients who survive might have in-hospital
complications. These complications are likely to have important short-term and long-…
complications. These complications are likely to have important short-term and long-…
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19
Background The long‐term sequalae of COVID‐19 remain poorly characterized. We assessed
persistent symptoms in previously hospitalized patients with COVID‐19 and assessed …
persistent symptoms in previously hospitalized patients with COVID‐19 and assessed …
[HTML][HTML] Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort …
…, JT Scott, T de Silva, L Sigfrid, T Solomon… - The Lancet …, 2021 - thelancet.com
Background Studies of patients admitted to hospital with COVID-19 have found varying
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …